Operating Lease, Right-of-Use Asset of enVVeno Medical Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
enVVeno Medical Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • enVVeno Medical Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $740,000, a 32% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

enVVeno Medical Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $740,000 -$350,000 -32% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $829,000 -$347,000 -30% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $925,000 -$336,000 -27% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $1,007,000 -$340,000 -25% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $1,090,000 -$336,000 -24% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $1,176,000 -$333,000 -22% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $1,261,000 -$330,000 -21% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,347,000 -$326,000 -19% 31 Dec 2023 10-K/A 28 Feb 2025 2024 FY
Q3 2023 $1,426,000 -$324,000 -19% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 $1,509,000 -$320,000 -17% 30 Jun 2023 10-Q 31 Jul 2023 2023 Q2
Q1 2023 $1,591,000 -$317,000 -17% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 $1,673,000 -$314,000 -16% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $1,750,000 +$1,438,210 +461% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 $1,829,000 +$1,441,148 +372% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $1,908,000 +$1,444,087 +311% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $1,987,000 +$1,447,026 +268% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $311,790 -$297,866 -49% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $387,852 -$294,051 -43% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $463,913 -$296,098 -39% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $539,974 -$286,423 -35% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $609,656 -$283,126 -32% 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 $681,903 -$279,752 -29% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $760,011 -$270,516 -26% 31 Mar 2020 10-Q 08 Jun 2020 2020 Q1
Q4 2019 $826,397 -$273,603 -25% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $892,782 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $961,655 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $1,030,527 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $1,100,000 31 Dec 2018 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.